Legal Representation
Attorney
Robert S. Weisbein
USPTO Deadlines
Next Deadline
1661 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-28)
Due Date
May 28, 2030
Grace Period Ends
November 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 28, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 28, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 12, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 12, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 21, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 21, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 6, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 6, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 12, 2024 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Jun 8, 2023 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| May 10, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 4, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 4, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Apr 28, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 28, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Nov 23, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Apr 18, 2022 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Aug 7, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Aug 7, 2021 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Aug 7, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jun 29, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 29, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 29, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 30, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 30, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 30, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 28, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 1, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 31, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Online retail pharmacy services; mail order pharmacy services; health care benefit and prescription hub services, namely, determining and communicating health care benefit price comparison information on behalf of patients and providers; healthcare business administration services, namely, administering patient reimbursement programs; business administration of pharmacy reimbursement programs and services; business information management; providing healthcare consulting services in the healthcare field for pharmaceutical, biotechnology and medical device suppliers, namely, business consulting services in the cost and payment management of health care; pharmaceutical cost management services; prescription drug utilization review services; patient relationship management services
First Use Anywhere:
20200200
First Use in Commerce:
20200200
Class 044
Providing information to patients in the field of administering medications; providing medical information to patients; patient health care counseling and advice regarding products in the field of prescription drugs; providing medical information in the field of adherence and compliance to prescribed medication dosing regimens
First Use Anywhere:
20200200
First Use in Commerce:
20200200
Class 045
Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication
First Use Anywhere:
20200200
First Use in Commerce:
20200200
Classification
International Classes
035
044
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACY"